Sub-section menu :

Content :

Communication/Conference: Counterfeit represent 20% of the sale of medicines in Brazil

Communication/Conference: Counterfeit represent 20% of the sale of medicines in Brazil

October 17th 2014 - www.cartacapital.com.br

The illegal sale of counterfeit medicines in Brazil is rapidly growing, representing this year 20% of the Brazilian pharmaceutical market for a total value estimated at over 3.2 billion US$ which is twice the world average according to the WHO.
Apart from the economic problematic linked to the counterfeiting of medicines (over 2 billion US$ from these sales are sent abroad), the presence of counterfeit medicines is rising and relayed by the Brazilian newspaper Carta Capital relating the sanitary incidents that occurred last September. The intoxication of children due to a counterfeited cough syrup resulted in the death of one of them; the product was made by an Indian laboratory and then imported through Paraguay.
Following this incident, the Brazilian national sanitary vigilance agency (Anvisa) recommended the population not to use treatments not approved by the national authorities.